Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$655M |
| 2 |
Coty
COTY
|
+$380M |
| 3 |
ConocoPhillips
COP
|
+$250M |
| 4 |
Zimmer Biomet
ZBH
|
+$213M |
| 5 |
Valero Energy
VLO
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$523M |
| 2 |
Merck
MRK
|
+$375M |
| 3 |
SHPG
Shire pic
SHPG
|
+$362M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$310M |
| 5 |
CELG
Celgene Corp
CELG
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.57% |
| 2 | Technology | 12.05% |
| 3 | Financials | 10.74% |
| 4 | Consumer Discretionary | 9.44% |
| 5 | Energy | 8.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Crown Castle
CCI
$32.1B
| $111M | 0.17% |
865,023
-656,122
| -43% | -$77M |
|
127
Wells Fargo
WFC
$254B
| $108M | 0.16% |
2,230,151
-3,163,349
| -59% | -$156M |
|
128
Monster Beverage
MNST
$93.6B
| $108M | 0.16% |
7,885,836
-28,912
| -0.4% | -$412K |
|
129
Stryker
SYK
$126B
| $107M | 0.16% |
542,865
-2,630
| -0.5% | -$473K |
|
130
lululemon athletica
LULU
$13.7B
| $107M | 0.16% |
653,978
+605,413
| +1,247% | +$88.4M |
|
131
JPMorgan Chase
JPM
$935B
| $107M | 0.16% |
1,053,600
+550,146
| +109% | +$56.7M |
|
132
Halliburton
HAL
$29.4B
| $107M | 0.16% |
3,637,988
+3,324,105
| +1,059% | +$100M |
|
133
Baxter International
BAX
$13.6B
| $106M | 0.16% |
1,306,506
+414,648
| +46% | +$30.2M |
|
134
Cummins
CMI
$80.9B
| $106M | 0.16% |
668,809
+168,370
| +34% | +$25.3M |
|
135
EQT Corp
EQT
$33.6B
| $105M | 0.16% |
5,074,647
-1,312,882
| -21% | -$25.7M |
|
|
XLNX
136
DELISTED
Xilinx Inc
XLNX
| $104M | 0.16% |
823,972
+28,508
| +4% | +$3.2M |
|
137
J.M. Smucker
SJM
$13.3B
| $103M | 0.15% |
882,906
+871,503
| +7,643% | +$91.1M |
|
138
Boeing
BA
$169B
| $103M | 0.15% |
269,554
-184,867
| -41% | -$71.2M |
|
|
CMA
139
DELISTED
Comerica
CMA
| $103M | 0.15% |
1,399,598
-1,983,125
| -59% | -$159M |
|
140
Netflix
NFLX
$331B
| $102M | 0.15% |
2,871,460
+1,505,710
| +110% | +$52.2M |
|
|
WMGI
141
DELISTED
Wright Medical Group Inc
WMGI
| $102M | 0.15% |
3,245,359
-1,093,230
| -25% | -$33.2M |
|
|
FDC
142
DELISTED
First Data Corporation
FDC
| $101M | 0.15% |
3,856,956
+2,273,054
| +144% | +$54M |
|
143
Zions Bancorporation
ZION
$9.95B
| $101M | 0.15% |
2,221,999
-1,691,497
| -43% | -$80.7M |
|
144
Rockwell Automation
ROK
$48.5B
| $99.9M | 0.15% |
569,595
-464,691
| -45% | -$79M |
|
145
Cencora
COR
$60.7B
| $99.8M | 0.15% |
1,255,008
+603,624
| +93% | +$48.5M |
|
146
Prudential Financial
PRU
$41.8B
| $99.4M | 0.15% |
+1,082,221
| New | +$99.8M |
|
147
NXP Semiconductors
NXPI
$56.9B
| $99.4M | 0.15% |
1,124,409
-1,422,374
| -56% | -$125M |
|
148
PepsiCo
PEP
$196B
| $99.4M | 0.15% |
810,784
+753,843
| +1,324% | +$85.9M |
|
149
Alliant Energy
LNT
$17.6B
| $98.6M | 0.15% |
2,092,848
-212,471
| -9% | -$9.51M |
|
150
Kohl's
KSS
$2B
| $98.6M | 0.15% |
1,434,157
+1,305,982
| +1,019% | +$88.6M |
|
Similar funds
Israel Englander's Q1 2019 Portfolio in Review
As of Q1 2019, Israel Englander held 4,608 positions worth $66.8B, up 4.2% from $64.1B the previous quarter. Its ten largest holdings account for 7.1% of the portfolio.
Israel Englander withdrew a net $6.14B in Q1 2019, closing 675 positions and reducing 1,467 holdings. Its most notable exit was Merck, an estimated $375M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 14% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Zimmer Biomet worth $232M.
- Israel Englander's largest Q1 2019 buy was Zimmer Biomet: 1,870,503 shares worth $232M.
- Israel Englander added most to Walt Disney in Q1 2019, an estimated $655M increase.
- Israel Englander's biggest Q1 2019 reduction was Apple, cutting an estimated $523M.
- Israel Englander fully exited Merck in Q1 2019, selling an estimated $375M.
- Israel Englander's ten largest holdings make up 7.1% of its $66.8B portfolio in Q1 2019.
- Israel Englander opened 914 new positions and closed 675 in Q1 2019.
- Israel Englander's portfolio value rose 4.2% quarter-over-quarter to $66.8B.
Based on Millennium Management's 13F filing for Q1 2019, filed 14 May 2019.